Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation

Journal of Clinical Oncology

Volumn 20, Issue 7, 2002, Pages 1845-1852

  Rischin, Danny ^a   Corry, June ^a   Smith, Jennifer ^a   Stewart, Josephine ^a   Hughes, Peter ^a   Peters, Lester ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INFUSION; DRUG SAFETY; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; HEARING LOSS; HISTOLOGY; HUMAN; MALE; MUCOSA INFLAMMATION; NASOPHARYNX CANCER; PRIORITY JOURNAL; RADIATION DOSE; SKIN TOXICITY; STOMATITIS; SURVIVAL RATE; VOMITING; XEROSTOMIA;

ADOLESCENT; ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036533894     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.07.011     Document Type: Article

References (18)

1. Advanced carcinoma of the nasopharynx: 2. Pattern of failure in 256 patients
2. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation
3. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: Overall survival and patterns of failure
4. Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil
5. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
6. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
7. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer
8. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099
9. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
10. Randomized trial comparing epirubicin, cisplatin and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer
11. Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: An active new regimen
12. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (≥ N2, MO) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival
13. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma
14. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma
15. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy
16. A phase III randomized trial comparing concurrent chemotherapy-radiotherapy with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma
17. Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional control
18. Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of distant metastasis and survival